Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents

Sharon B. Murphy*, Elaine R. Morgan, Howard M. Katzenstein, Morris Kletzel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations


Purpose: The nodular lymphocyte-predominant form of Hodgkin disease (LPHD) is a distinct clinicopathologic entity with a favorable prognosis. To see if children and adolescents could be spared the adverse sequelae of treatment, the authors adopted a policy of little or no treatment of localized LPHD in 1989. Patients and Methods: Presentation, pathology, and outcomes were reviewed for 15 consecutive children and adolescents with LPHD seen at a single institution since 1989. One patient was lost to follow-up and two patients were seen only once in consultation and treated elsewhere. These three cases were excluded, leaving twelve: nine males and three females, ranging in age at diagnosis from 2 to 17 years (median 11). Eleven of the 12 had stage I disease, and 1 had stage II. Six received no treatment following excisional biopsy, while five received a brief treatment with chemotherapy only. One was initially treated with involved field radiotherapy (IFRT) due to an initially imprecise histologic diagnosis of classic Hodgkin disease. Results: All patients are alive, without evidence of disease, for periods ranging from 2 to 13+ years after diagnosis (median 6 years). One patient recurred locally with LPHD 6 years after initial brief chemotherapy and was then treated with IFRT, achieving a prolonged second remission. Conclusion: Children and adolescents with localized LPHD have an excellent prognosis and may be safely approached either with a wait-and-see attitude of no initial therapy after initial adenectomy or with less aggressive treatments.

Original languageEnglish (US)
Pages (from-to)684-687
Number of pages4
JournalJournal of pediatric hematology/oncology
Issue number9
StatePublished - Sep 1 2003


  • Hodgkin disease
  • Lymphocyte-predominant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents'. Together they form a unique fingerprint.

Cite this